4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-26-038522
Options or other derivatives
- SrVP/CFO/Prin Fin & Acct Ofcr bought 61,956 shares at $0.81 ($24,999)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2026-03-31 | Purchase · Pre-Funded Warrant | +30,978 | $0.81 | $24,999 | 30,978 | D |
| Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2026-03-31 | Purchase · Common Warrant | +30,978 | 30,978 | D | ||
Loading xslF345X06/tm2610878-2_4seq1.xml…